Cosmetics Europe Strategizing To Defend Ingredients Flagged As Endocrine Disruptors, CMRs

Clarification of requirements and a “demanding” timeline for industry’s defense of cosmetic ingredients identified as potentially carcinogenic, mutagenic or reprotoxic, and the Commission’s forthcoming list of potential endocrine disruptors in cosmetic products, are among challenges facing Cosmetics Europe in 2019 and beyond.

3d render of Europe map Earth globe

Cosmetics Europe is preparing for challenges amid EU regulatory movement to clamp down on endocrine disruptors while also strategizing to defend CMR (carcinogenic, mutagenic or reprotoxic) substances within what could be a narrow timeframe for industry to build its case.

More from Europe

EU Probiotics Deadlock: Ombudsman Finds ‘No Maladministration’ By The Commission

 
• By 

In response to an IPA Europe complaint, European Ombudsman Emily O’Reilly finds that the Commission’s interpretation of EU food legislation in relation to probiotics is “reasonable and in line with the main goal of this legislation, which is to ensure a high level of consumer protection.”

UK Honors PAGB’s Riddalls And ISF’s Webber For Self-Care Service

 
• By 

PAGB CEO Michelle Riddalls and ISF president emeritus David Webber have been awarded OBEs for their services to consumer health and self-care.

Kenvue Survey Shows UK Pharmacists United Behind Self-Care Solutions

 
• By 

A recent Kenvue survey shows that an overwhelming majority of UK pharmacists believe many health issues could be prevented through better self-care.

France Reverse-Switches Pseudoephedrine OTCs Over Long-Running Safety Concerns

 
• By 

Oral pseudoephedrine decongestants marketed by Kenuve, Haleon and Opella, amongst others, are now only available with a doctor's prescription in France.

More from Geography